These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20846263)

  • 81. DNA hypomethylation of interleukin 8 in clear cell renal cell carcinoma.
    Yoo KH; Park YK; Chang SG
    Oncol Lett; 2013 Jan; 5(1):39-42. PubMed ID: 23255890
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Methylation markers of early-stage non-small cell lung cancer.
    Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
    PLoS One; 2012; 7(6):e39813. PubMed ID: 22768131
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Identification of novel epigenetic markers for clear cell renal cell carcinoma.
    Dalgin GS; Drever M; Williams T; King T; DeLisi C; Liou LS
    J Urol; 2008 Sep; 180(3):1126-30. PubMed ID: 18639284
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features.
    Kim DS; Kim MJ; Lee JY; Lee SM; Choi JY; Yoon GS; Na YK; Hong HS; Kim SG; Choi JE; Lee SY; Park JY
    Mol Carcinog; 2009 Dec; 48(12):1109-15. PubMed ID: 19554572
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma.
    Eggers H; Steffens S; Grosshennig A; Becker JU; Hennenlotter J; Stenzl A; Merseburger AS; Kuczyk MA; Serth J
    Int J Oncol; 2012 May; 40(5):1650-8. PubMed ID: 22327210
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
    Okuda H; Toyota M; Ishida W; Furihata M; Tsuchiya M; Kamada M; Tokino T; Shuin T
    Oncogene; 2006 Mar; 25(12):1733-42. PubMed ID: 16278676
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma.
    Yoo KH; Park YK; Kim HS; Jung WW; Chang SG
    Pathol Int; 2010 Oct; 60(10):661-6. PubMed ID: 20846263
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma].
    Zhang Q; Jin J; Tao Q
    Ai Zheng; 2007 Nov; 26(11):1276-80. PubMed ID: 17991333
    [TBL] [Abstract][Full Text] [Related]  

  • 90. HOXA5: A crucial transcriptional factor in cancer and a potential therapeutic target.
    Fan F; Mo H; Zhang H; Dai Z; Wang Z; Qu C; Liu F; Zhang L; Luo P; Zhang J; Liu Z; Cheng Q; Ding F
    Biomed Pharmacother; 2022 Nov; 155():113800. PubMed ID: 36271576
    [TBL] [Abstract][Full Text] [Related]  

  • 91.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.